*To be consumed as directed by physician.
Therapies:
Hormonal
Composition:
Letrozole (2.5Mg)
Letero 2.5Mg is an anti-cancer drug that belongs to the class aromatase inhibitor. It is indicated as a supportive therapy after the main therapy or first-line therapy for postmenopausal women with early and advanced breast cancer whose tumors are hormone receptor-positive. Since high amounts of Estrogen are found to trigger breast cancer, this medicine reduces the levels of the female reproductive hormone by blocking the enzyme (aromatase) that is involved in the production of Estrogen. This medicine aims to slow or stop the growth and/or spreading to other body parts.
*To be consumed as directed by physician.
